Thermo Fisher Scientific Inc. (TMO) is a Technology stock trading at $627.62 (as of 2026-08-20), with a market capitalization of $233.24B and a trailing P/E of 33.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Thermo Fisher Scientific provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. Its offerings include reagents, instruments, consumables, and related services for research and drug and vaccine development, as well as diagnostic testing products and instruments, serving pharmaceutical, biotechnology, academic, government, clinical, and other healthcare and industrial customers across multiple regions.
Thermo Fisher Scientific sells life sciences solutions and laboratory products, including reagents, instruments, consumables, analytical instruments, and specialty diagnostics, and also provides biopharma services and clinical research support to pharma, biotech, and other customers.
Thermo's profit engine blends product sales (reagents, instruments, and consumables, plus analytical instruments and specialty diagnostics) with service revenue (biopharma services and clinical research, including its PPD business).
| LPBS | $6.0B |
| LifeSci | $2.6B |
| Analytical | $1.9B |
| SpecDx | $1.1B |
Business quality (Mixed): This view is grounded in reported segment revenue labels, but the only available operating KPIs here are revenue-based, with no deeper operational activity metrics provided.
Valuation: At 27× earnings, TMO trades 55% below the Measuring & Control Equipment average (60×). Note: one-time items can distort reported P/E.
| Price | $627.62 |
| Market Cap | $233.24B |
| P/E Ratio | 33.5 |
| EV / EBITDA | 29.5 |
| Price / Book | 4.43 |
| Price / Sales | 5.03 |
| FCF Yield | 3.1% |
| DCF Value (model) | $98.53 |
| DCF Upside vs Price | -84.3% |
| Revenue (TTM) | $44.56B |
| Net Margin | 15.0% |
| Revenue Growth (YoY) | 10.5% |
| EPS Growth (YoY) | 9.3% |
| FCF Growth (YoY) | 51.6% |
| Altman Z-Score | 3.99 (safe) |
| Stock P/E | 33.5 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
| vs Sector | -1.3% |
| vs Industry | -35.4% |
| Insider Sells (12mo) | 26 |
| Top Institutional Holder | VANGUARD GROUP INC ($19.78B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 10 |
| Sector | Technology |
| Industry | Measuring & Control Equipment |
| CEO | Marc N. Casper |
| Employees | 125,000 |
| Country | US |
| IPO Date | 1980-03-17 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.